Astellas Pharma Inc.
[WKN: 856273 | ISIN: JP3942400007]
Aktienkurse
9,658€ -1,07%
Echtzeit-Aktienkurs Astellas Pharma Inc.
Bid: Ask:

Echtzeit-Chart der Astellas Pharma Inc. Aktie

Astellas Pharma Inc. Chart

Charttool öffnen

Börsenkurse Astellas Pharma Inc.

Börse Stuttgart - - - - 9,658€ -1,49%
Börse Frankfurt - - - - 9,584€ -0,19%
gettex - - - - 9,713€ -1,67%
Tradegate - - - - 9,658€ -0,71%
Lang & Schwarz - - - - 9,653€ -1,65%
Echtzeit Euro - - - - 9,658€ -1,07%

Profil der Astellas Pharma Inc. Aktie

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.